rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paula H. Cholmondeley

Other role

Company insider

Files Form 4 as: Director and Other, Terex; Director, Lexeo Therapeutics; Director, Kapstone Paper & Packaging; Director, Bank Of The Ozarks; Director, Dentsply Sirona; Director, Minerals Technologies; Director, Albany International; Director, Ultralife.

In numbers

Trades disclosed
292
Buys
31
Sells
19
Bought
$1.6M
Sold
$3.5M
Companies
8
Companies where not an officer
8
First trade
2 Nov 2005
Last trade
26 Jun 2026
Last filed
30 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TEX TerexDirector, Other · Machinery · last 26 Jun 202613 buys · 7 sells
LXEO Lexeo TherapeuticsDirector · Biotechnology · last 25 Jun 20261 buy · 0 sells
Kapstone Paper & PackagingDirector · last 2 Nov 20181 buy · 0 sells
Bank Of The OzarksDirector · last 8 May 20172 buys · 0 sells
XRAY Dentsply SironaDirector · Medical Devices · last 8 Jan 20161 buy · 3 sells
MTX Minerals TechnologiesDirector · Chemicals · last 13 Mar 20142 buys · 0 sells
AIN Albany InternationalDirector · Apparel, Footwear & Luxury · last 14 May 20123 buys · 3 sells
ULBI UltralifeDirector · Electronic Components & EMS · last 15 May 20108 buys · 6 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 Jun 2026filed 30 Jun 2026TEX TerexMachinerySEC FORM 4 Code A$81K1,128 at $71.81filing
26 Jun 2026filed 30 Jun 2026TEX TerexMachinerySEC FORM 4 Code A$81K1,128 at $71.81filing
25 Jun 2026filed 29 Jun 2026LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
25 Jun 2026filed 29 Jun 2026LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
26 Jun 2025filed 30 Jun 2025LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
25 Nov 2024filed 26 Nov 2024LXEO Lexeo TherapeuticsBiotechnologySEC FORM 4 Bought$105K15,000 at $6.99filing
25 Jun 2024filed 27 Jun 2024LXEO Lexeo Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—18,000 at $0.00filing
4 Nov 2022filed 8 Nov 2022TEX TerexMachinerySEC FORM 4 Sold$824K20,000 at $41.22filing
30 Sep 2020filed 1 Oct 2020TEX TerexMachinerySEC FORM 4 Sold$56K2,853 at $19.61filing
30 Sep 2020filed 1 Oct 2020TEX TerexMachinerySEC FORM 4 Bought$56K2,853 at $19.47filing
19 Mar 2020filed 20 Mar 2020TEX TerexMachinerySEC FORM 4 Bought$253K20,000 at $12.64filing
7 Jun 2019filed 11 Jun 2019TEX TerexMachinerySEC FORM 4 Sold$75K2,653 at $28.24filing
7 Jun 2019filed 11 Jun 2019TEX TerexMachinerySEC FORM 4 Bought$42K1,500 at $28.23filing
7 Jun 2019filed 11 Jun 2019TEX TerexMachinerySEC FORM 4 Bought$33K1,153 at $28.24filing
2 Nov 2018filed 6 Nov 2018Kapstone Paper & Packagingoption or derivativeSEC FORM 4 Code D—1,607filing
2 Nov 2018filed 6 Nov 2018Kapstone Paper & PackagingSEC FORM 4 Code D—29,697.37filing
2 Nov 2018filed 6 Nov 2018Kapstone Paper & PackagingSEC FORM 4 Code D—2,944filing
30 Oct 2018filed 1 Nov 2018Kapstone Paper & PackagingSEC FORM 4 Code M$121K5,458 at $22.20filing
30 Oct 2018filed 1 Nov 2018Kapstone Paper & PackagingSEC FORM 4 Code F$121K3,464 at $34.98filing
30 Oct 2018filed 1 Nov 2018Kapstone Paper & PackagingSEC FORM 4 Code M$25K1,607 at $15.49filing

News

Sectors

Industrials20
Technology14
Consumer Discretionary6
Health Care5
Materials2
Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Patrick S. CarrollPres., Environmental Solutions · Pres., Environmental Solutions at Terex, filing Form 4 there in the last year
Jennifer Kong-PicarelloSenior Vice President, CFO · Senior Vice President, CFO at Terex, filing Form 4 there in the last year
Narinder Pal BhallaChief Medical Officer · Chief Medical Officer at Lexeo Therapeutics, filing Form 4 there in the last year
Louis Edward TamayoChief Financial Officer · Chief Financial Officer at Lexeo Therapeutics, filing Form 4 there in the last year
Richard Nolan TownsendChief Executive Officer · Chief Executive Officer at Lexeo Therapeutics, filing Form 4 there in the last year
Jose Manuel OteroChief Operating Officer · Also traded LXEO in the last 90 days